Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study to Evaluate the Safety and Efficacy of CD10367 in Subjects With Psoriasis

NCT03025282 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT03025282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03025282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study to Evaluate the Safety and Efficacy of CD10367 in Subjects With Psoriasis
Lead sponsor
Galderma R&D
Phase
Phase 2
Overall status
Completed
Start date
November 3, 2016
Completion date
March 24, 2017
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris